<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0039">
 <label>39.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zeng</surname>
    <given-names>LP</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ge</surname>
    <given-names>XY</given-names>
   </name>, 
   <name name-style="western">
    <surname>Peng</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Tai</surname>
    <given-names>W</given-names>
   </name>, 
   <name name-style="western">
    <surname>Jiang</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Du</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shi</surname>
    <given-names>ZL</given-names>
   </name>
  </person-group>
  <article-title>Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses</article-title>. 
  <source>Sci China Life Sci</source>. 
  <year>2017</year>;
  <volume>60</volume>(
  <issue>12</issue>):
  <fpage>1399</fpage>â€“
  <lpage>402</lpage>. doi:
  <pub-id pub-id-type="doi">10.1007/s11427-017-9189-3</pub-id>.
  <pub-id pub-id-type="pmid">29134417</pub-id>
 </mixed-citation>
</ref>
